We describe a general method to locate the positions of cysteine residues relative to the amino terminus of a protein, using a modified chemical cleavage of the polypeptide backbone at cysteine. The cleavage reaction introduces the carbon atom of 14CN into the carboxyl-terminal fragment produced at each cleavage of the polypeptide chain. Peptides containing the amino terminus of the intact protein are not labeled; all other peptides are labeled at their amino termini. Partial cleavage of a protein followed by gel electrophoresis and autoradiography identifies a ladder of unlabeled peptides that maps positions of the cysteine residues relative to the protein amino terminus. To map individual proteins present in a complex mixture, the polypeptides are cyanolated in solution with '4CN, and the modified proteins are separated by discontinuous SDS/PAGE. The gel is stained, and the desired protein is excised, cleaved at cysteine within the gel slice, and mapped in the second dimension by gel electrophoresis. These techniques are demonstrated with proteins of known sequence containing from zero to five cysteine residues. The cysteine "landmark map" should be particularly useful in locating protein modifications, in questions of protein similarity, and in mapping functional domains. A strategy is also presented for locating other residues in the polypeptide, for which specific cleavage methods exist.
Protein mapping is a powerful biochemical tool frequently used to localize functional domains and modifications of proteins, to compare two or more similar polypeptides, and to aid protein sequencing. Mapping generally involves the specific cleavage of a protein into discrete peptides, the resolution of these peptides, and their localization within the protein sequence. Many specific methods for both cleavage of a protein and resolution of the resulting peptides exist. At present, at least three general methods locate some or all partial cleavage products of a protein within its primary structure. (i) The first method uses a series of reactions to label the protein at its amino terminus before cleavage and so is restricted to those proteins with unblocked amino termini (1) . ( ii) The second method employs a two-dimensional mapping technique to identify products of a partial CNBr cleavage of the protein at methionine residues (2) . The complexity and resolution requirements of this technique limit its practical use to those proteins with few and simply distributed methionine residues, a relatively common amino acid. ( iii) The third method compares by HPLC the partial cleavage products of the intact protein with a similar cleavage of a limited carboxypeptidase-digestion product of the protein (3); this requires extensive digestion of the protein by carboxypeptidase in the absence of any endopeptidase activity, which has generally proven difficult.
We used a modified cysteine cleavage reaction (4, 5) to generate an ordered map of the protein's cysteine residues, the most rare amino acid. Peptides thus identified can then be used to map cleavage sites other than cysteine within the protein and to identify partial cleavage products of the protein obtained from these sites. The entire procedure is simple and rapid, can be done with submicrogram amounts of material isolated by SDS/PAGE, and does not require an unblocked amino terminus.
METHODS
Chemicals and Proteins. Reagents of the highest purity commercially available were used. K14CN (50 mCi/mmol; 1 Ci = 37 GBq) was purchased from Amersham. Calmodulin from bovine brain and rabbit skeletal muscle actin were purified as described (6, 7); rabbit skeletal muscle creatine kinase was purchased from Sigma. The 8 subunit of spinach chloroplast coupling factor 1 (CF1/3) was the gift of M. Richter and R. McCarty (Cornell University).
Cysteine Cleavage in Solution and Primary Mapping. Pure protein was incubated in 100 mM Tris-HCl, pH 8.0/8 M urea/5 mM dithiothreitol at room temperature for 20 min to reduce cystine. This solution was made 15 mM 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), pH 8.0, incubated for 15 min, dialyzed against 1000 vol of 50% (vol/vol) acetic acid at room temperature, and lyophilized to dryness. Protein solubility in 50% acetic acid may be a problem and so care must be taken to resuspend any protein precipitated within the dialysis bag. The Iyophilized 2-nitro-5-thiobenzoic acidcysteine-modified protein samples can be stored at -20°C for months with no discernible effect on cyanolation or cleavage.
To cyanolate and cleave the 2-nitro-5-thiobenzoic acidcysteine-modified protein, the lyophilized protein was dissolved in cleavage buffer (100 mM sodium borate/500 mM glycylglycine/8 M urea, pH 9.0), made 1 mM K14CN (50 mCi/mmol) from a 100 mM aqueous K14CN stock solution, and incubated at 40°C for the indicated times. The reaction mixture was then made 100 mM dithiothreitol and incubated at 40°C for 15 min to remove any remaining 14CN moieties from uncleaved cyanocysteine residues, effectively stopping the cleavage reaction. Peptide products of the cleavage reaction were resolved by SDS/PAGE (8, 9) and visualized by Coomassie blue R-250 (9) or silver staining (10) . All stained gels were photographed after drying on a transparent, colorless membrane (Bio-Rad). To detect 14C-labeled iminothiazolidine-4-carboxylyl ([14C]ITC) peptides, Coomassie blue-stained gels were autoradiographed, and silver stained gels were fluorographed (11) at -70°C on Kodak XAR-5 film.
Silver staining greatly decreases the sensitivity of 14C detection by fluorography; to avoid this, duplicate samples can be run (one stained and the other fluorographed). Alternatively, Abbreviations: ITC, iminothiazolidine-4-carboxylyl; TIC, Tricine/ imidazole chloride; CF113, the 8 subunit of chloroplast coupling factor 1.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (12) or the discontinuous Tricine/imidazole chloride (TIC) gel system (see below). When the SDS/phosphate gel system was used, the protein solution was made 10 mM sodium phosphate, pH 7.3/10% glycerol/0.02% bromophenol blue before running the gel. This gel system prepared as described (12) and prerun for at least 400 V-hr reduces cross-linking artifacts seen with some proteins. After replacing the reservoir buffer, the sample was loaded. The resolved cyanocysteine-modified proteins were visualized with Coomassie blue R-250. Absolute ethanol was used in place of reagent-grade methanol in both staining and destaining solutions to reduce protein crosslinking. The band containing the cyanocysteinemodified protein of interest was then excised, placed in a 1.5-ml Microfuge tube, and washed twice with distilled water for 10 min at room temperature with constant shaking to remove the destain solution. After equilibration with water, the stained cyanocysteine-modified protein bands can be stored for months at -70°C before cleavage.
For cleavage, the gel slice was placed in a 1.5-ml Microfuge tube and equilibrated three times for 10 min with cleavage buffer G (2 M glycylglycine NaOH/100 mM sodium borate/8 M urea, pH 9.0) at room temperature with constant shaking. The buffer was then removed, and the gel slice was incubated at 40°C for 1-4 hr. The gel slice was then equilibrated three times for 15 min with sample buffer (8) with constant shaking at room temperature and loaded directly onto the resolving gel (8, 9) . Good physical contact should be maintained between the gel slice and the top of the second-dimension gel to avoid loss of resolution or possible generation of artifactual bands. Once in place the gel slice is overlaid with a 1% agarose solution of the reservoir buffer. The resolved peptide products of the cleavage reaction are silver stained and fluorographed. Gloves should be worn during preparation of all solutions and throughout the cleavage procedure.
TIC Discontinuous Gel System. The standard 37:1 acrylamide/bisacrylamide ratio was used in all gels (8 
RESULTS AND DISCUSSION
Cysteine Mapping Strategy. The basic mapping strategy is shown schematically in Fig. 1 . The hypothetical protein has two cysteine residues, which divide its sequence into three regions designated 1, 2, and 3. The first two steps lead to specific cyanolation and then partial cleavage of the protein at its cysteine residues with K14CN. Cleavage at the amino peptide bonds of the modified cysteine residues occurs at elevated pH in an intramolecular, hydroxide ion-catalyzed, ring-closure reaction involving the cyanide carbon atom (4 ITC moiety containing the 14C atom. The 14C atom has been introduced into the protein and its cleavage products in two forms: the CN moiety of cyanocysteine residues and the ITC group. The cyanide group on the cyanocysteine residues can be quantitatively removed by treatment with excess dithiothreitol, reforming cysteine and thereby stopping the cleavage reaction. By contrast, the ITC group is stable under these conditions (4, 5) . After reduction, the family of partial cysteine cleavage products containing the amino terminus of the intact protein are not labeled, whereas all other peptides are stoichiometrically end-labeled on their amino terminus with [14CJITC (step 3). The reaction products are then resolved by gel electrophoresis, stained for protein, and autoradiographed (step 4). Comparison of the protein stain and autoradiograph identifies the ladder of unlabeled peptides that contains the amino terminus of the intact protein (peptides 1, 1-2, and 1-2-3) . The molecular mass of each unlabeled polypeptide determines the position of the cysteine residue in the intact protein that was cleaved to produce it. The only other partial-cleavage product that can be immediately identified is the labeled peptide of highest molecular mass (2-3 in the example), which extends from first cysteine to carboxyl terminus.
Given a protein with P cysteine residues there are (P + 1) (P + 2)/2 possible partial cleavage products, including the intact protein. P + 1 of these peptides contain the amino terminus of the intact protein and are unlabeled. Ideally, both the total number of cleavage products and the number of unlabeled products indicate the number and position of all cysteine residues in the protein. But in practice, this derived number depends, among other things, upon relative peptide abundance and SDS/PAGE resolution and, therefore, should be taken as a minimum. Because cleavage at different cysteine residues in a protein can occur at different rates, it is prudent to perform a time course of the cleavage reaction to ensure that all resolvable amino-terminal fragments have been obtained. Even without a resolved amino-terminal fragment, the redundancy of information within the cysteine map can sometimes be used to deduce the existence and location of a cysteine residue, as demonstrated below.
Cysteine Mapping of Pure Proteins in Solution. To test our mapping strategy, proteins of known sequence with zero to five cysteine residues were selected. Attempts to employ existing cysteine cleavage protocols (4, 5) failed, as almost all peptide products were labeled to similar specific activities in a dithiothreitol-irreversible manner. We found that the presence of 500 mM glycylglycine during cyanolation and cleavage at pH 9.0 reduces this background labeling, yielding unambiguous cysteine maps. This result is illustrated in Fig.   2 for rabbit skeletal muscle creatine kinase, which has four cysteine residues, as indicated (13) . A complete set of reduced partial cleavage products is expected to contain 15 different peptides, 10 of which should be labeled on their amino terminus with [14C]ITC, and 5, containing the amino terminus of the intact protein, should not be labeled. Rabbit skeletal muscle creatine kinase runs anomalously slowly on SDS gels, having an apparent mass 5 kDa greater than the value determined from its sequence. This fact is reflected in the derived map and the region of the protein giving rise to this anomaly is located between the third and fourth cysteine residue (region 4) (Fig. 2) .
Actin is a 43-kDa polypeptide containing 375 amino acids (14) , five of which are cysteines, as shown in Fig. 2 . Their distribution presents a significant challenge to our mapping strategy. Thirteen peptides can be identified by SDS/PAGE of the partial cysteine cleavage products of actin, suggesting a minimum of four resolvable cleavage sites in the intact protein. Biochemistry: Nefsky and Bretscher unlabeled peptides, including the intact protein, are evident, indicating either a lost or unresolved amino-terminal reaction product. The highest molecular mass-labeled peptide contains all the amino acids from the first cysteine residue to the carboxyl terminus. From the difference in molecular mass between the intact protein and this peptide we can estimate the molecular mass ofthe peptide from the amino terminus up to the first cysteine, peptide 1. For actin this difference is =1 kDa, clearly less than 23 kDa, the size of the smallest identified unlabeled peptide. The missing unlabeled peptide can therefore be identified as peptide 1, and the corresponding cysteine can be placed 10 amino acids from the amino terminus. The smallest unlabeled peptide on this gel is thus composed of the sequence from the amino terminus to the amino acid preceding the second cysteine residue. Positions of the four cysteine residues in the deduced map agree with the known sequence. Actin, however, has five cysteine residues, only four of which are mapped. The unmapped cysteine is the penultimate amino acid of the protein, and no cleavage products from this site can be resolved by SDS/PAGE.
Cysteine Mapping of Proteins Isolated by SDS Gel Electrophoresis. The simplicity and resolution of SDS/PAGE have made it the method ofchoice for separating complex mixtures of polypeptides. The ability to map proteins isolated by SDS/PAGE within gel slices greatly extends the potential applications of this analysis. Initially we attempted both to cyanolate and cleave polypeptides isolated within a gel slice. Inefficient cyanolation and high background labeling of the protein and its cleavage products made this approach impractical.
To avoid these problems, we denatured all components of a protein mixture and subjected them to the '4C cyanolation reaction in solution at neutral pH before electrophoresis. Nearly quantitative cyanolation of cysteine residues occurs under these conditions. The cyanocysteine-modified proteins formed are not stable under the alkaline conditions used in Laemmli gels (8) resolved on a 15% TIC gel. The protein stain and autoradiograph of the gel are shown in Fig. 3 , lanes A and B. As expected, both creatine kinase and CF1f3 were labeled, and calmodulin was not. Gel slices containing the cyanolated proteins were excised, and the proteins were cleaved in situ by incubation at pH 9. The peptide products of the cleavage reaction were then resolved by SDS/PAGE in the second dimension and visualized by silver stain (Fig. 3, lanes D, F, and H) . The labeled products were identified by fluorography of an unstained duplicate sample (Fig. 3, lanes C, E, and G) (2) , N-chlorosuccinimide at tryptophan (17) , acid hydrolysis at aspartic acid-proline (18) , and hydroxylamine Approach for localizing specific cleavage sites within the cysteine landmark map. This figure shows the basic strategy, as applied to a hypothetical protein with two cysteine residues (SH), which divide the protein into regions 1, 2, and 3, and two tryptophan residues (W), positioned as shown; the latter divides the protein into three other regions designated A, B, and C. The intact protein and its 14CN-cysteine cleavage products, fragment 1 and fragment 2-3 isolated by SDS/PAGE, are subjected to a cleavage reaction specific for tryptophan residues within the gel slice. The products resulting from each reaction are resolved by SDS/PAGE in the second dimension. Lanes A, B, and C depict the cleavage products obtained from fragment 1, the intact protein 1-2-3, and fragment 2-3, respectively. Lane D is the predicted fluorograph of lane C. Fragments that can be immediately identified are indicated.
at asparagine-glycine (19) are cleaved in SDS/PAGE-isolated cysteine fragments. As an example, let us suppose we wish to locate the tryptophan residues within the hypothetical protein shown in Fig. 4 . One useful approach, outlined in Fig.  4 , is to compare the partial cleavage products of the intact protein with two peptides that span the complete sequence.
The intact protein, its largest labeled cysteine fragment (composed of the amino acids from the first cysteine to the carboxyl terminus), and the smallest cysteine peptide containing the amino terminus are excised from the gel, and each is subjected to partial chemical cleavage at tryptophan. The products are resolved with SDS/PAGE followed by silver staining and fluorography. Compare the products generated from the intact protein and both cysteine fragments (lanes A, B, and C). The peptides unique to the cleavage reaction ofthe largest labeled fragment share a common amino terminus, the [I4C]ITC group of the first cysteine residue, and terminate at each ofthe tryptophan residues in this cysteine fragment. The molecular mass of these peptides maps the distance between the first cysteine residue and their corresponding tryptophan. The same peptides can be identified by fluorography (lane D). The amino-terminal cysteine peptide chosen cannot be cleaved at tryptophan (lane A), indicating that no tryptophan residues lie between the amino terminus of the protein and its first cysteine. Thus, the peptides unique to cleavage products of the intact protein have the same amino terminus as the intact protein and one of the protein's resolvable tryptophan cleavage sites on their carboxyl terminus. The molecular masses of these peptides map the corresponding tryptophan cleavage sites relative to the amino terminus. If there are tryptophan cleavage sites within the amino-terminal peptide, the molecular masses of its unique partial cleavage products map these sites relative to the carboxyl terminus of the fragment (and thus to the corresponding cysteine residue in the protein). A comparison of the partial cleavage products obtained from other identified cysteine fragments of the protein can be used to confirm the map; the information gained is redundant and can usually be used to resolve ambiguities in the map.
Landmark mapping offers a simple and rapid method of localizing many protein modifications, such as phosphorylation, glycosylation, and proteolysis sites, and should prove useful in protein sequencing. Regions of heterogeneity between isoforms and antibody epitopes can be easily mapped. 
